Clinical Trial Update: Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update suggests warfarin may prevent portal vein thrombosis in liver cirrhosis patients with hypersplenism following laparoscopic splen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Vein Thrombosis

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: Yangzhou University | Conditions: Cirrhosis, Hypertension | Phase 4 | Status: UNKNOWN